Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 46, Issue 2, Pages 556-557Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.46.2.556-557.2002
Keywords
-
Categories
Ask authors/readers for more resources
We susceptibility tested 17 clinical isolates of Aspergillus fumigates, for most of which MICs of itraeonazole were elevated (MIC at which 50% of the isolates tested are inhibited, 16 mug/ml), against itraconazole, posaconazole, ravuconazole, and voriconazole. Posaconazole was the most active against itraconazole-susceptible isolates. A complex pattern of cross-resistance and hypersusceptibility was seen with voriconazole and ravuconazole, suggesting marked differences in activity and mechanisms of resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available